Drug Shortage Report for DIAZEPAM INJECTION USP
| Report ID | 131820 |
| Drug Identification Number | 00399728 |
| Brand name | DIAZEPAM INJECTION USP |
| Common or Proper name | DIAZEPAM INJECTION USP |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 2ML 10LIAM CA |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-15 |
| Estimated end date | 2021-01-29 |
| Actual end date | 2021-01-22 |
| Shortage status | Resolved |
| Updated date | 2021-01-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-01-25 | French | Compare |
| v3 | 2021-01-25 | English | Compare |
| v2 | 2021-01-18 | French | Compare |
| v1 | 2021-01-18 | English | Compare |
Showing 1 to 4 of 4